Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IL › CHICAGO › APUSHKIN, MARSHA

APUSHKIN, MARSHA

NPI: 1922341445 · CHICAGO, IL 60657 · Anatomic Pathology & Clinical Pathology Physician · NPI assigned 04/03/2013

$1.00M
Total Medicaid Paid
113,974
Total Claims
83,674
Beneficiaries
118
Codes Billed
2018-01
First Month
2024-11
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 512 $7K
2019 725 $13K
2020 532 $12K
2021 475 $17K
2022 445 $18K
2023 30,656 $238K
2024 80,629 $695K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 3,487 2,851 $177K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 3,457 3,080 $169K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,639 2,242 $76K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,808 1,547 $54K
85027 15,687 9,509 $45K
80053 Comprehensive metabolic panel 8,337 5,872 $43K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 121 108 $35K
80048 Basic metabolic panel (calcium, ionized) 6,153 3,547 $25K
82805 1,342 462 $25K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 715 643 $20K
83880 1,552 1,168 $19K
84443 Thyroid stimulating hormone (TSH) 2,077 1,798 $17K
88307 337 287 $16K
87400 2,058 1,692 $16K
84484 3,376 2,509 $15K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 84 70 $15K
86480 518 478 $14K
83735 4,065 1,725 $13K
86703 1,467 1,370 $12K
83036 Hemoglobin; glycosylated (A1C) 3,136 2,671 $10K
82948 4,429 1,578 $9K
80061 Lipid panel 2,829 2,359 $9K
83690 2,501 2,017 $8K
81025 3,162 2,748 $8K
83605 1,441 904 $7K
87040 762 608 $7K
85610 3,686 2,856 $7K
85730 2,229 1,836 $7K
87430 826 733 $6K
87340 1,091 1,029 $6K
80074 309 256 $6K
81000 4,477 4,044 $6K
82607 787 664 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 541 504 $5K
85384 1,371 1,127 $4K
84702 882 764 $4K
86592 2,084 1,913 $4K
87088 852 768 $4K
82550 1,597 1,122 $3K
88312 166 149 $3K
86803 451 417 $3K
87480 238 214 $3K
87510 238 214 $3K
83655 469 456 $3K
88304 163 146 $3K
84100 1,892 645 $3K
80164 550 444 $2K
86850 740 597 $2K
84439 494 435 $2K
83020 240 216 $2K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 267 253 $2K
82728 473 405 $2K
85379 517 442 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 72 67 $2K
87081 584 501 $2K
82553 405 244 $2K
84436 488 433 $2K
80076 450 378 $1K
83540 420 344 $1K
86900 813 674 $1K
88342 102 97 $1K
85007 636 416 $1K
80202 160 78 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 76 72 $1K
87420 143 116 $1K
88300 156 141 $1K
83550 276 225 $1K
85651 402 333 $888.30
86901 314 232 $712.80
82010 284 188 $707.14
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 313 308 $689.28
88160 33 30 $675.15
88141 137 121 $569.09
86762 125 110 $564.87
87186 112 99 $545.58
85660 227 204 $530.80
82747 72 64 $473.03
80185 68 54 $441.32
G0103 Prostate cancer screening; prostate specific antigen test (psa) 50 44 $440.00
84153 62 60 $402.60
87070 125 113 $399.90
86694 54 48 $366.85
82570 141 114 $361.39
82746 63 54 $340.94
84481 57 52 $289.56
82140 56 43 $285.60
84060 81 50 $279.94
84165 97 97 $264.28
86336 27 27 $245.78
83970 16 14 $238.07
86140 99 85 $231.01
82105 28 27 $221.67
80305 31 30 $208.94
86706 32 32 $203.78
82677 27 27 $203.02
80069 55 24 $200.71
82670 15 15 $146.70
83498 15 15 $142.65
82626 16 16 $141.60
83001 15 15 $136.35
82947 74 63 $135.61
85018 125 101 $129.92
82043 61 55 $120.09
84550 77 70 $113.44
85014 95 83 $112.52
87075 18 14 $106.74
83002 15 15 $97.20
87205 54 49 $94.50
82950 40 34 $93.20
86787 12 12 $90.16
82248 62 25 $83.04
86735 12 12 $76.20
82951 12 12 $75.60
80178 20 15 $71.06
83525 15 15 $66.45
84479 15 14 $47.85
82952 12 12 $26.74
36415 Collection of venous blood by venipuncture 55 50 $0.00